Table of Contents
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 6
1.2
List of Figures 8
2 Introduction 9
2.1 What Is This Report About?
9
3 Definitions of Markets Covered in the Report 10
3.1 Diabetes Care
Devices 10
3.2 Glucose Monitoring Devices 10
3.2.1 Blood Glucose
Meters 10
3.2.2 Blood Glucose Strips 10
3.3 Insulin Delivery 10
3.3.1 Insulin Pens 10
3.3.2 Insulin Syringes 11
3.3.3 Insulin Pumps
11
3.3.4 Traditional Insulin Pump Accessories 11
4 Healthcare Sector
Review 12
4.1 Healthcare Expenditure 12
4.2 Healthcare Infrastructure
15
4.3 Healthcare Policy 19
5 Regulation System 20
5.1 Medical
Equipment Approval Process 20
5.1.1 Classification 20
5.1.2 Premarket
Notification for Class I Devices 21
5.1.3 Pre-market Approval for Class
II, III and IV Devices 21
5.1.4 License Fee 22
5.1.5 License
Application Processing Duration 22
5.2 Post-market Surveillance 23
6
Pricing and Reimbursement 24
7 Distribution Structure 27
7.1
Distribution Structure 27
8 Diabetes Care Devices In Republic of Korea
28
8.1 Diabetes Care Devices, Cross Country Comparison, Revenue ($ mn),
2000-2015 28
8.2 Diabetes Care Devices, Republic of Korea, Overall Revenue
($ mn), 2000-2015 29
8.3 Diabetes Care Devices, Republic of Korea,
Category Volume (Units), 2000-2015 33
8.4 Diabetes Care Devices, Republic
of Korea, Company Share (2007-2008) 36
9 Glucose Monitoring In Republic of
Korea 37
9.1 Glucose Monitoring Overall Revenue (2000-2015) 37
9.2
Glucose Monitoring Overall Volume (2000-2015) 39
9.3 Glucose Monitoring
Average Price (2000-2015) 41
9.4 Glucose Monitoring Distribution Share
(2007-2008) 41
9.5 Glucose Monitoring, Republic of Korea, Company Share
(2007-2008) 42
10 Insulin Delivery In Republic of Korea 43
10.1
Insulin Delivery Overall Revenue (2000-2015) 43
10.1.1 Insulin Pens
Revenue (2000-2015) 45
10.2 Insulin Delivery Overall Volume (2000-2015)
47
10.2.1 Insulin Pens Volume (2000-2015) 48
10.3 Insulin Delivery
Average Price (2000-2015) 50
10.4 Insulin Delivery Distribution Share
(2007-2008) 51
10.5 Insulin Delivery, Republic of Korea, Company Share
(2007-2008) 52
11 Overview of Key Companies in Republic of Korea Diabetes
Care Devices Market 53
11.1 Terumo Corporation 53
11.1.1 Company
Overview 53
11.1.2 Value Chain Analysis 53
11.2 Smiths Medical 56
11.2.1 Company Overview 56
11.2.2 Value Chain Analysis 56
11.3
Sanofi-Aventis 58
11.3.1 Company Overview 58
11.4 Novo Nordisk A/S
59
11.4.1 Company Overview 59
11.4.2 Novo Nordisk A/S Pipeline
Products 59
11.5 Medtronic, Inc. 60
11.5.1 Company Overview 60
11.5.2 Value Chain Analysis 61
11.5.3 Medtronic, Inc. Pipeline Products
63
11.6 LifeScan, Inc. 71
11.6.1 Company Overview 71
11.6.2
LifeScan, Inc. Pipeline Products 71
11.7 F. Hoffmann-La Roche Ltd. 73
11.7.1 Company Overview 73
11.7.2 Value Chain Analysis 73
11.7.3 F.
Hoffmann-La Roche Ltd Pipeline Products 75
11.8 Eli Lilly and Company
77
11.8.1 Company Overview 77
11.8.2 Value Chain Analysis 77
11.8.3 Eli Lilly and Company Pipeline Products 79
11.9 Becton, Dickinson
and Company 81
11.9.1 Company Overview 81
11.9.2 Value Chain Analysis
81
11.10 Bayer HealthCare AG 83
11.10.1 Company Overview 83
11.10.2 Value Chain Analysis 83
11.10.3 Bayer HealthCare AG Pipeline
Products 85
11.11 ARKRAY, Inc. 87
11.11.1 Company Overview 87
11.11.2 ARKRAY, Inc. Pipeline Products 87
11.12 Apex Biotechnology Corp.
88
11.12.1 Company Overview 88
11.13 Animas Corporation 88
11.13.1
Company Overview 88
11.14 Abbott Laboratories 89
11.14.1 Company
Overview 89
11.14.2 Value Chain Analysis 90
11.14.3 Abbott
Laboratories Pipeline Products 92
11.15 Shina Corporation 93
11.15.1
Company Overview 93
12 Appendix 94
12.1 Global Markets Direct Research
Methodology 94
12.2 Coverage 95
12.3 Secondary Research 95
12.4
Primary Research 96
12.5 Models 96
12.6 Forecasts 97
12.7 Expert
Panel Validation 97
12.8 Currency Conversion 98
12.9 Contact Us 99
12.10 Disclaimer 99
1.1 List of Tables
Table 1:
Hospital Wards by Specialty in Republic of Korea, 2003-2007 16
Table 2:
Doctors by Specialty in Republic of Korea, 2003-2007 17
Table 3:
Healthcare Institutions in Republic of Korea, 2001-2005 18
Table 4:
Healthcare Personnel in Republic of Korea, 1975-2002 18
Table 5:
Classification of Medical Equipment in Republic of Korea 20
Table 6:
Diabetes Care Devices, Cross Country Comparison, Revenue ($ mn), 2000-2015
28
Table 7: Diabetes Care Devices, Republic of Korea, Overall Revenue
($ mn), 2000-2015 29
Table 8: Diabetes Care Devices, Republic of
Korea, Cross-Category Analysis, 2000-2015 30
Table 9: Diabetes Care
Devices, Republic of Korea, Overall Revenue ($ mn), Historic, 2000-2008 31
Table 10: Diabetes Care Devices, Republic of Korea, Overall Revenue ($
mn), Forecast, 2008-2015 32
Table 11: Diabetes Care Devices, Republic
of Korea, Category Volume (Units), 2000-2015 33
Table 12: Diabetes
Care Devices, Republic of Korea, Category Volume (Units), Historic, 2000-2008
34
Table 13: Diabetes Care Devices, Republic of Korea, Category
Volume (Units), Forecast, 2008-2015 35
Table 14: Diabetes Care
Devices, Republic of Korea, Company Share by Revenue ($ mn), 2007-2008 36
Table 15: Glucose Monitoring, Republic of Korea, Revenue ($ mn) by
Segment, Historic, 2000-2008 37
Table 16: Glucose Monitoring,
Republic of Korea, Revenue ($ mn) by Segment, Forecast, 2008-2015 38
Table
17: Glucose Monitoring, Republic of Korea, Volume (Units) by Segment,
Historic, 2000-2008 39
Table 18: Glucose Monitoring, Republic of
Korea, Volume (Units) by Segment, Forecast, 2008-2015 40
Table 19:
Glucose Monitoring, Republic of Korea, Average Price ($), Historic, 2000-2008
41
Table 20: Glucose Monitoring, Republic of Korea, Average Price
($), Forecast,, 2008-2015 41
Table 21: Glucose Monitoring, Republic
of Korea, Distribution Share by Revenue ($mn), 2007-2008 41
Table 22:
Glucose Monitoring, Republic of Korea, Company Share by Revenue ($ mn),
2007-2008 42
Table 23: Insulin Delivery, Republic of Korea, Revenue
($ mn) by Segment, Historic, 2000-2008 43
Table 24: Insulin Delivery,
Republic of Korea, Revenue ($ mn) by Segment, Forecast, 2008-2015 44
Table
25: Insulin Pens, Republic of Korea, Revenue ($ mn) by Sub-Segment,
Historic, 2000-2008 45
Table 26: Insulin Pens, Republic of Korea,
Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 46
Table 27:
Insulin Delivery, Republic of Korea, Volume (Units) by Segment, Historic,
2000-2008 47
Table 28: Insulin Delivery, Republic of Korea, Volume
(Units) by Segment, Forecast, 2008-2015 47
Table 29: Insulin Pens,
Republic of Korea, Volume (Units) by Sub-Segment, Historic, 2000-2008 48
Table 30: Insulin Pens, Republic of Korea, Volume (Units) by Sub-Segment,
Forecast, 2008-2015 49
Table 31: Insulin Delivery, Republic of Korea,
Average Price ($), Historic, 2000-2008 50
Table 32: Insulin Delivery,
Republic of Korea, Average Price ($), Forecast,, 2008-2015 50
Table 33:
Insulin Delivery, Republic of Korea, Distribution Share by Revenue ($mn),
2007-2008 51
Table 34: Insulin Delivery, Republic of Korea, Company
Share by Revenue ($ mn), 2007-2008 52
Table 35: Novo Nordisk A/S
Pipeline Products by Equipment Type 59
Table 36: Novo Nordisk A/S
Pipeline Products By Development Stage 59
Table 37: Novo Nordisk A/S
Pipeline Products By Therapy Area 59
Table 38: Novo Nordisk A/S
Pipeline Products By Clinical Trials 59
Table 39: Medtronic, Inc.
Pipeline Products by Equipment Type 63
Table 40: Medtronic, Inc.
Pipeline Products By Development Stage 65
Table 41: Medtronic, Inc.
Pipeline Products By Therapy Area 67
Table 42: Medtronic, Inc.
Pipeline Products By Clinical Trials 69
Table 43: Medtronic, Inc.
Pipeline Products By News Summary 70
Table 44: LifeScan, Inc.
Pipeline Products by Equipment Type 71
Table 45: LifeScan, Inc.
Pipeline Products By Development Stage 71
Table 46: LifeScan, Inc.
Pipeline Products By Therapy Area 72
Table 47: LifeScan, Inc.
Pipeline Products By Clinical Trials 72
Table 48: LifeScan, Inc.
Pipeline Products By News Summary 72
Table 49: F. Hoffmann-La Roche
Ltd Pipeline Products by Equipment Type 75
Table 50: F. Hoffmann-La
Roche Ltd Pipeline Products By Development Stage 76
Table 51: F.
Hoffmann-La Roche Ltd Pipeline Products By Therapy Area 76
Table 52:
Eli Lilly and Company Pipeline Products by Equipment Type 79
Table 53:
Eli Lilly and Company Pipeline Products By Development Stage 80
Table 54:
Eli Lilly and Company Pipeline Products By Therapy Area 80
Table 55:
Eli Lilly and Company Pipeline Products By Clinical Trials 80
Table
56: Eli Lilly and Company Pipeline Products By News Summary 80
Table
57: Bayer HealthCare AG Pipeline Products by Equipment Type 85
Table
58: Bayer HealthCare AG Pipeline Products By Development Stage 86
Table 59: Bayer HealthCare AG Pipeline Products By Therapy Area 86
Table 60: Bayer HealthCare AG Pipeline Products By News Summary 86
Table 61: ARKRAY, Inc. Pipeline Products by Equipment Type 87
Table
62: ARKRAY, Inc. Pipeline Products By Development Stage 87
Table 63:
ARKRAY, Inc. Pipeline Products By Clinical Trials 87
Table 64:
ARKRAY, Inc. Pipeline Products By News Summary 88
Table 65: Abbott
Laboratories Pipeline Products by Equipment Type 92
Table 66: Abbott
Laboratories Pipeline Products By Development Stage 92
Table 67:
Abbott Laboratories Pipeline Products By Therapy Area 92
Table 68: USD
to Local Currency, Average Exchange Rate 2008 98
1.2 List
of Figures
Figure 1: Healthcare Financing in Republic of Korea, 2007
13
Figure 2: Healthcare Expenditure in Republic of Korea, 2000 - 2006
14
Figure 3: Evaluation (Value Appraisal) Criteria for Medical Device
Reimbursement in Republic of Korea, 2007 25
Figure 4: Medical Device
Pricing System in Republic of Korea, 2007 26
Figure 5: Diabetes Care
Devices, Cross Country Comparison, Revenue ($ mn), 2000-2015 28
Figure 6:
Diabetes Care Devices, Republic of Korea, Overall Revenue ($ mn),
2000-2015 29
Figure 7: Diabetes Care Devices, Republic of Korea,
Cross-Category Analysis, 2000-2015 30
Figure 8: Diabetes Care
Devices, Republic of Korea, Overall Revenue ($ mn), Historic, 2000-2008 31
Figure 9: Diabetes Care Devices, Republic of Korea, Overall Revenue ($
mn), Forecast, 2008-2015 32
Figure 10: Diabetes Care Devices,
Republic of Korea, Category Volume (Units), 2000-2015 33
Figure 11:
Diabetes Care Devices, Republic of Korea, Category Volume (Units), Historic,
2000-2008 34
Figure 12: Diabetes Care Devices, Republic of Korea,
Category Volume (Units), Forecast, 2008-2015 35
Figure 13: Diabetes
Care Devices, Republic of Korea, Company Share (%), 2008 36
Figure 14:
Glucose Monitoring, Republic of Korea, Revenue ($ mn) by Segment, Historic,
2000-2008 37
Figure 15: Glucose Monitoring, Republic of Korea,
Revenue ($ mn) by Segment, Forecast, 2008-2015 38
Figure 16: Glucose
Monitoring, Republic of Korea, Volume (Units) by Segment, Historic, 2000-2008
39
Figure 17: Glucose Monitoring, Republic of Korea, Volume (Units)
by Segment, Forecast, 2008-2015 40
Figure 18: Glucose Monitoring,
Republic of Korea, Company Share (%), 2008 42
Figure 19: Insulin
Delivery, Republic of Korea, Revenue ($ mn) by Segment, Historic, 2000-2008
43
Figure 20: Insulin Delivery, Republic of Korea, Revenue ($ mn) by
Segment, Forecast, 2008-2015 44
Figure 21: Insulin Pens, Republic of
Korea, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 45
Figure 22:
Insulin Pens, Republic of Korea, Revenue ($ mn) by Sub-Segment, Forecast,
2008-2015 46
Figure 23: Insulin Pens, Republic of Korea, Volume
(Units) by Sub-Segment, Historic, 2000-2008 48
Figure 24: Insulin
Pens, Republic of Korea, Volume (Units) by Sub-Segment, Forecast, 2008-2015
49
Figure 25: Insulin Delivery, Republic of Korea, Company Share (%),
2008 52
Figure 26: Terumo Corporation Value Chain Analysis 53
Figure 27: Smiths Medical Value Chain Analysis 56
Figure 28:
Medtronic, Inc. Value Chain Analysis 61
Figure 29: F. Hoffmann-La
Roche Ltd Value Chain Analysis 73
Figure 30: Eli Lilly and Company
Value Chain Analysis 77
Figure 31: Becton, Dickinson and Company
Value Chain Analysis 81
Figure 32: Bayer HealthCare AG Value Chain
Analysis 83
Figure 33: Abbott Laboratories Value Chain Analysis
90
Figure 34: Global Markets Direct Methodology 94
|
Related Report
|
View Cart
